HC Wainwright Has Negative Outlook for CATX Q3 Earnings
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – HC Wainwright reduced their Q3 2025 EPS estimates for shares of Perspective Therapeutics in a research report issued to clients and investors on Monday, May 19th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($0.31) for the quarter, down […]
Perspective Therapeutics, Inc. (NYSE:CATX – Free Report) – HC Wainwright reduced their Q3 2025 EPS estimates for shares of Perspective Therapeutics in a research report issued to clients and investors on Monday, May 19th. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per share of ($0.31) for the quarter, down […]
